Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations

TAS-117 is a potent and selective allosteric pan-v-akt murine thymoma viral oncogene homolog (Akt) inhibitor. We conducted a single-arm single-center phase 2 study of TAS-117 in heavily treated patients with tumors refractory to systemic chemotherapy and harboring phosphatidylinositol 3-kinase (PI3K...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jii Bum, Jung, Minkyu, Beom, Seung Hoon, Kim, Gun Min, Kim, Hye Ryun, Choi, Hye Jin, Sohn, Joo Hyuk, Ahn, Joong Bae, Rha, Sun Young, Chung, Hyun Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Phase II Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426297/
https://www.ncbi.nlm.nih.gov/pubmed/33723724
http://dx.doi.org/10.1007/s10637-021-01085-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426297/
https://www.ncbi.nlm.nih.gov/pubmed/33723724
http://dx.doi.org/10.1007/s10637-021-01085-7

Ejemplares similares